TY  - GEN
AU  - Cheang,M C U
AU  - Bliss,J M
AU  - Viale,G
AU  - Speirs,V
AU  - Palmieri,C
AU  - Shaaban,A
AU  - Lønning,P E
AU  - Morden,J
AU  - Porta,N
AU  - Jassem,J
AU  - van De Velde,C J
AU  - Rasmussen,B B
AU  - Verhoeven,D
AU  - Bartlett,J M S
AU  - Coombes,R C
TI  - Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES
SN  - 1573-7217
PY  - 2019///0319
KW  - Aged
KW  - Androstadienes
KW  - pharmacology
KW  - Antineoplastic Agents, Hormonal
KW  - Breast
KW  - pathology
KW  - Breast Neoplasms
KW  - mortality
KW  - Chemotherapy, Adjuvant
KW  - methods
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Mastectomy
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - epidemiology
KW  - Prognosis
KW  - Receptors, Estrogen
KW  - metabolism
KW  - Receptors, Progesterone
KW  - Tamoxifen
KW  - Time Factors
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1007/s10549-017-4543-7
ER  -